The drug, called CagriSema, was generally safe, with nausea, vomiting, diarrhea and constipation among the most common side effects similar to those seen with other GLP-1 treatments already on the market
Final regulatory approval is expected in the coming months
CJC-1295 No DAC, also referred to as Modified GRF 1-29, is a modified analogue of growth hormone-releasing hormone used in research models examining short-acting GHRH receptor pathway activity
Symptoms include: Difficulty breathing or swallowing Severe rash or itching Swelling of your face, lips, tongue, or throat If you experience these serious side effects, talk with your medical provider right away
Most liposuction patients can return to work within a few days to a week, depending on the extent of the procedure
A 2023 case series published in the Journal of Lymphatic Research documented an unexpected pattern: lipedema patients using semaglutide for metabolic weight loss experienced reduced trunk fat but unchanged leg volume